AB138. Experience on thulium laser treatment in transurethral resection of bladder tumor

OBJECTIVE: To study the safety and efficacy of thulium laser treatment of bladder cancer. METHODS: Thulium laser surgery system was used for the treatment of 45 cases of bladder cancer patients, including 33 cases of single tumor, 12 cases of multiple tumors. Tumor diameter were 5–25 mm. Tumor pathology were bladder transitional cell carcinoma, clinical stage at T1–T2. RESULTS: All the surgery was successfully completion. Operation time was 10–35 minutes. Blood loss was 0–5 mL. None of bladder has perforation, water intoxication, urinary leakage or postoperative bleeding. All of the patients had received immediate intravesical chemotherapy within 0.5 hours, and to maintain bladder chemotherapy. All had catheter indwelled 5 to 7 days. Patients were followed up 1 year, no recurrence of the surgical area. CONCLUSIONS: Thulium laser surgery system for the transurethral treatment of bladder cancer within stage T2 is safe and effective.